Belgium finalises purchase of 20,000 courses of Paxlovid and Molnupiravir
The Belgian government finalises an agreement to acquire 20,000 courses of Pfizer's Paxlovid and Merck & Co.'s Molnupiravir for at-home treatment of COVID-19.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthBelgium finalises purchase of 20,000 courses of Paxlovid and Molnupiravir
Sign in or subscribeBrowse free archive reportsThe Belgian government finalises an agreement to acquire 20,000 courses of Pfizer's Paxlovid and Merck & Co.'s Molnupiravir for at-home treatment of COVID-19.